Logitech International (LOGI) 10-Q26 Jan 232023 Q3 Quarterly reportFinancial data

Company Profile

Cover Page

Cover Page - shares	9 Months Ended
Cover Page - shares	Dec. 31, 2022	Jan. 12, 2023
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Dec. 31, 2022
Document Transition Report	false
Entity File Number	0-29174
Entity Registrant Name	LOGITECH INTERNATIONAL S.A.
Entity Incorporation, State or Country Code	V8
Entity Address, Address Line One	1015 Lausanne
Entity Address, Country	CH
Entity Address, Address Line Two	c/o Logitech Inc.
Entity Address, Address Line Three	7700 Gateway Boulevard
Entity Address, City or Town	Newark
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94560
City Area Code	510
Local Phone Number	795-8500
Title of 12(b) Security	Registered Shares
Trading Symbol	LOGI
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		160,304,010
Entity Central Index Key	0001032975
Amendment Flag	false
Current Fiscal Year End Date	--03-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Income Statement [Abstract]
Net sales	$ 1,269,925	$ 1,632,782	$ 3,578,741	$ 4,251,107
Cost of goods sold	789,489	971,646	2,193,735	2,470,980
Amortization of intangible assets	3,168	3,126	9,355	11,028
Gross profit	477,268	658,010	1,375,651	1,769,099
Operating expenses:
Marketing and selling	196,653	269,941	628,122	778,882
Research and development	65,640	75,529	210,166	213,436
General and administrative	29,766	38,478	92,215	112,291
Amortization of intangible assets and acquisition-related costs	2,810	3,662	9,052	13,986
Impairment of intangible assets	0	7,000	0	7,000
Change in fair value of contingent consideration for business acquisition	0	(1,110)	0	(3,509)
Restructuring charges, net	5,654	1,759	16,471	1,770
Total operating expenses	300,523	395,259	956,026	1,123,856
Operating income	176,745	262,751	419,625	645,243
Interest income	4,665	278	9,573	795
Other income (expense), net	1,406	(3,673)	(18,367)	(1,941)
Income before income taxes	182,816	259,356	410,831	644,097
Provision for income taxes	42,663	49,345	87,751	107,789
Net income	$ 140,153	$ 210,011	$ 323,080	$ 536,308
Net income per share:
Basic (in dollars per share)	$ 0.87	$ 1.26	$ 1.98	$ 3.19
Diluted (in dollars per share)	$ 0.86	$ 1.24	$ 1.96	$ 3.14
Weighted average shares used to compute net income per share:
Basic (in shares)	161,244	167,090	163,042	167,953
Diluted (in shares)	162,529	169,707	164,427	171,027

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Statement of Comprehensive Income [Abstract]
Net income	$ 140,153	$ 210,011	$ 323,080	$ 536,308
Currency translation gain (loss):
Currency translation gain (loss), net of taxes	33,076	(5,806)	(6,207)	(9,733)
Reclassification of cumulative translation adjustments included in other income (expense), net	219	0	219	1,051
Defined benefit plans:
Net gain (loss) and prior service costs, net of taxes	(104)	(443)	8	(848)
Reclassification of amortization included in other income (expense), net	(112)	211	(338)	634
Hedging gain (loss):
Deferred hedging gain (loss), net of taxes	(6,325)	1,061	5,239	3,723
Reclassification of hedging gain included in cost of goods sold	(4,728)	(3,200)	(11,766)	(5,108)
Total other comprehensive gain (loss)	22,026	(8,177)	(12,845)	(10,281)
Total comprehensive income	$ 162,179	$ 201,834	$ 310,235	$ 526,027

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2022	Mar. 31, 2022
Current assets:
Cash and cash equivalents	$ 1,036,131	$ 1,328,716
Accounts receivable, net	802,435	675,604
Inventories	797,695	933,124
Other current assets	125,088	135,478
Total current assets	2,761,349	3,072,922
Non-current assets:
Property, plant and equipment, net	118,183	109,807
Goodwill	454,471	448,175
Other intangible assets, net	69,364	83,779
Other assets	335,879	320,722
Total assets	3,739,246	4,035,405
Current liabilities:
Accounts payable	491,488	636,306
Accrued and other current liabilities	705,569	784,848
Total current liabilities	1,197,057	1,421,154
Non-current liabilities:
Income taxes payable	117,608	83,380
Other non-current liabilities	165,915	132,133
Total liabilities	1,480,580	1,636,667
Commitments and contingencies
Shareholders’ equity:
Registered shares, CHF 0.25 par value: Issued shares - 173,106 at September 30, 2022 and March 31, 2022 Additional shares that may be be issued out of conditional capitals - 50,000 at September 30,2022 and March 31, 2022 Additional shares that may be issued out of authorized capital - 17,311 at September 30, 2022 and March 31, 2022	30,148	30,148
Additional paid-in capital	116,012	129,925
Shares in treasury, at cost — 12,470 at December 31, 2022 and 7,855 at March 31, 2022	(906,606)	(632,893)
Retained earnings	3,136,080	2,975,681
Accumulated other comprehensive loss	(116,968)	(104,123)
Total shareholders’ equity	2,258,666	2,398,738
Total liabilities and shareholders’ equity	$ 3,739,246	$ 4,035,405

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - SFr / shares shares in Thousands	Dec. 31, 2022	Mar. 31, 2022
Statement of Financial Position [Abstract]
Shares, par value (in CHF per share)	SFr 0.25	SFr 0.25
Shares issued (in shares)	173,106	173,106
Shares that may be issued out of conditional capital (in shares)	50,000	50,000
Shares that may be issued out of the authorized capital (in shares)	17,311	17,311
Treasury, at cost, shares (in shares)	12,470	7,855

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Cash flows from operating activities:
Net income	$ 323,080	$ 536,308
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	56,698	65,387
Amortization of intangible assets	18,173	24,223
Impairment of intangible assets	0	7,000
Loss on investments	13,065	1,421
Share-based compensation expense	51,740	72,465
Deferred income taxes	24,228	27,369
Change in fair value of contingent consideration for business acquisition	0	(3,509)
Other	1,411	1,068
Changes in assets and liabilities, net of acquisitions:
Accounts receivable, net	(123,547)	(236,358)
Inventories	126,309	(177,828)
Other assets	20,918	(20,569)
Accounts payable	(134,848)	(80,637)
Accrued and other liabilities	(60,060)	(17,612)
Net cash provided by operating activities	317,167	198,728
Cash flows from investing activities:
Purchases of property, plant and equipment	(69,122)	(63,726)
Investment in privately held companies	(2,626)	(1,260)
Acquisitions, net of cash acquired	(8,527)	(15,886)
Purchases of short-term investments	0	(10,000)
Proceeds from the sale of short-term investments	0	1,225
Purchases of deferred compensation investments	(5,186)	(3,644)
Proceeds from sales of deferred compensation investments	4,750	4,285
Net cash used in investing activities	(80,711)	(89,006)
Cash flows from financing activities:
Payment of cash dividends	(158,680)	(159,410)
Payment of contingent consideration for business acquisition	(5,954)	(880)
Purchases of registered shares	(327,731)	(290,625)
Proceeds from exercises of stock options and purchase rights	16,064	16,644
Tax withholdings related to net share settlements of restricted stock units	(28,734)	(58,528)
Net cash used in financing activities	(505,035)	(492,799)
Effect of exchange rate changes on cash and cash equivalents	(24,006)	(2,839)
Net decrease in cash and cash equivalents	(292,585)	(385,916)
Cash and cash equivalents, beginning of the period	1,328,716	1,750,327
Cash and cash equivalents, end of the period	1,036,131	1,364,411
Non-cash investing and financing activities:
Property, plant and equipment purchased during the period and included in period end liability accounts	9,250	13,707
Non-cash contingent consideration for acquisition	2,151	9,013
Right-of-use assets obtained in exchange for operating lease liabilities	42,814	0
Supplemental cash flow information:
Income taxes paid, net	$ 65,154	$ 175,775

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Registered Shares	Additional Paid-in Capital	Treasury Shares	Retained Earnings	Accumulated Other Comprehensive Loss
Beginning of the period at Mar. 31, 2021	$ 2,261,789	$ 30,148	$ 129,519	$ (279,541)	$ 2,490,578	$ (108,915)
Beginning of the period (in shares) at Mar. 31, 2021		173,106
Beginning of the period (in shares) at Mar. 31, 2021				4,799
Increase (Decrease) in Shareholders' Equity
Total comprehensive income	526,027				536,308	(10,281)
Purchases of registered shares	(290,625)			$ (290,625)
Purchases of registered shares (in shares)				3,035
Sales of shares upon exercise of stock options and purchase rights	16,644		8,397	$ 8,247
Sales of shares upon exercise of stock options and purchase rights (in shares)				(226)
Issuance of shares upon vesting of restricted stock units	(58,528)		(93,967)	$ 35,439
Issuance of shares upon vesting of restricted stock units (in shares)				(969)
Share-based compensation	72,045		72,045
Cash dividends	(159,410)				(159,410)
End of the period at Dec. 31, 2021	2,367,942	$ 30,148	115,994	$ (526,480)	2,867,476	(119,196)
End of the period (in shares) at Dec. 31, 2021		173,106
End of the period (in shares) at Dec. 31, 2021				6,639
Beginning of the period at Sep. 30, 2021	2,262,683	$ 30,148	99,434	$ (413,345)	2,657,465	(111,019)
Beginning of the period (in shares) at Sep. 30, 2021		173,106
Beginning of the period (in shares) at Sep. 30, 2021				5,331
Increase (Decrease) in Shareholders' Equity
Total comprehensive income	201,834				210,011	(8,177)
Purchases of registered shares	(116,245)			$ (116,245)
Purchases of registered shares (in shares)				1,379
Sales of shares upon exercise of stock options and purchase rights	8		8
Issuance of shares upon vesting of restricted stock units	(3,777)		(6,887)	$ 3,110
Issuance of shares upon vesting of restricted stock units (in shares)				(71)
Share-based compensation	23,439		23,439
End of the period at Dec. 31, 2021	2,367,942	$ 30,148	115,994	$ (526,480)	2,867,476	(119,196)
End of the period (in shares) at Dec. 31, 2021		173,106
End of the period (in shares) at Dec. 31, 2021				6,639
Beginning of the period at Mar. 31, 2022	$ 2,398,738	$ 30,148	129,925	$ (632,893)	2,975,681	(104,123)
Beginning of the period (in shares) at Mar. 31, 2022		173,106
Beginning of the period (in shares) at Mar. 31, 2022	7,855			7,855
Increase (Decrease) in Shareholders' Equity
Total comprehensive income	$ 310,235				323,080	(12,845)
Purchases of registered shares	(327,731)			$ (327,731)
Purchases of registered shares (in shares)				5,967
Sales of shares upon exercise of stock options and purchase rights	16,064		(930)	$ 16,994
Sales of shares upon exercise of stock options and purchase rights (in shares)				(423)
Issuance of shares upon vesting of restricted stock units	(28,734)		(65,758)	$ 37,024
Issuance of shares upon vesting of restricted stock units (in shares)				(929)
Share-based compensation	52,775		52,775
Cash dividends	(162,681)				(162,681)
End of the period at Dec. 31, 2022	$ 2,258,666	$ 30,148	116,012	$ (906,606)	3,136,080	(116,968)
End of the period (in shares) at Dec. 31, 2022		173,106
End of the period (in shares) at Dec. 31, 2022	12,470			12,470
Beginning of the period at Sep. 30, 2022	$ 2,168,561	$ 30,148	106,130	$ (824,650)	2,995,927	(138,994)
Beginning of the period (in shares) at Sep. 30, 2022		173,106
Beginning of the period (in shares) at Sep. 30, 2022				10,943
Increase (Decrease) in Shareholders' Equity
Total comprehensive income	162,179				140,153	22,026
Purchases of registered shares	(90,170)			$ (90,170)
Purchases of registered shares (in shares)				1,746
Sales of shares upon exercise of stock options and purchase rights	3,214		(2,582)	$ 5,796
Sales of shares upon exercise of stock options and purchase rights (in shares)				(155)
Issuance of shares upon vesting of restricted stock units	(1,992)		(4,410)	$ 2,418
Issuance of shares upon vesting of restricted stock units (in shares)				(64)
Share-based compensation	16,874		16,874
End of the period at Dec. 31, 2022	$ 2,258,666	$ 30,148	$ 116,012	$ (906,606)	$ 3,136,080	$ (116,968)
End of the period (in shares) at Dec. 31, 2022		173,106
End of the period (in shares) at Dec. 31, 2022	12,470			12,470

CONDENSED CONSOLIDATED STATEM_5

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical)	9 Months Ended
	Dec. 31, 2022 $ / shares	Dec. 31, 2022 SFr / shares	Dec. 31, 2021 $ / shares	Dec. 31, 2021 SFr / shares
Statement of Stockholders' Equity [Abstract]
Cash dividends per share (in dollars per share) \| (per share)	$ 1	SFr 0.96	$ 0.95	SFr 0.87

The Company and Summary of Sign

The Company and Summary of Significant Accounting Policies and Estimates	9 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
The Company and Summary of Significant Accounting Policies and Estimates	The Company and Summary of Significant Accounting Policies and Estimates The Company Logitech International S.A, together with its consolidated subsidiaries ("Logitech" or the "Company"), designs, manufactures and markets products that help connect people to digital and cloud experiences. Over forty years ago, Logitech created products to improve experiences around the personal computer ("PC") platform, and today it is a multi-brand, multi-category company designing products that enable better experiences consuming, sharing and creating any digital content such as computing, gaming, video, and music, whether it is on a computer, mobile device or in the cloud. The Company sells its products to a broad network of domestic and international customers, including direct sales to retailers, e-tailers and enterprise customers, and indirect sales through distributors. Logitech was founded in Switzerland in 1981 and Logitech International S.A. has been the parent holding company of Logitech since 1988. Logitech International S.A. is a Swiss holding company with its registered office in Hautemorges, Switzerland, and headquarters in Lausanne, Switzerland, which conducts its business through subsidiaries in the Americas, Europe, Middle East and Africa ("EMEA") and Asia Pacific. Shares of Logitech International S.A. are listed on both the SIX Swiss Exchange under the trading symbol LOGN and the Nasdaq Global Select Market under the trading symbol LOGI. Basis of Presentation The condensed consolidated financial statements include the accounts of Logitech and its subsidiaries. All intercompany balances and transactions have been eliminated. The condensed consolidated financial statements are presented in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial information and therefore do not include all the information required by U.S. GAAP for complete financial statements. The condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements for the fiscal year ended March 31, 2022, included in its Annual Report on Form 10-K filed with the Securities and Exchange Commission ("SEC") on May 18, 2022. In the opinion of management, these condensed consolidated financial statements include all adjustments, consisting of only normal and recurring adjustments, necessary and in all material aspects, for a fair statement of the results of operations, comprehensive income, financial position, cash flows and changes in shareholders' equity for the periods presented. Operating results for the three and nine months ended December 31, 2022 are not necessarily indicative of the results that may be expected for the fiscal year ending March 31, 2023, or any future periods. Changes in Significant Accounting Policies Other than the recent accounting pronouncements adopted and discussed below under Recent Accounting Pronouncements Adopted , there have bee n no material changes in the Company’s significant accounting policies during the nine months ended December 31, 2022 compared with the significant accounting policies described in its Annual Report on Form 10-K for the fiscal year ended March 31, 2022. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and various other assumptions believed to be reasonable. Significant estimates and assumptions made by management involve the fair value of goodwill and intangible assets acquired from business acquisitions, contingent consideration for a business acquisition and periodic reassessment of its fair value, valuation of investment in privately held companies classified under Level 3 fair value hierarchy, pension obligations, accruals for customer incentives, cooperative marketing, and pricing programs and related breakage when appropriate, inventory valuation, share-based compensation expense, uncertain tax positions, and valuation allowances for deferred tax assets. Although these estimates are based on management’s best knowledge of current events and actions that may impact the Company in the future, actual results could differ materially from those estimates. Risks and Uncertainties Impacts of Macroeconomic and Geopolitical Conditions and Other Factors on the Company's Business In March 2020, the World Health Organization declared the outbreak of COVID-19 as a pandemic, which continues to spread throughout the world. The COVID-19 pandemic resulted in industry-wide global supply chain challenges, including manufacturing, transportation and logistics. The Company purchases certain products and key components from a limited number of sources, and depends on the supply chain, including freight, to receive components, transport finished goods and deliver the Company's products across the world. More recently, the Company has also been impacted by adverse macroeconomic and geopolitical conditions. These conditions include but are not limited to inflation, foreign currency fluctuations, and slowdown of economic activity around the world, in part due to rising interest rates, and lower consumer and enterprise spending . In addition, the war in Ukraine increased global supply chain, logistics, and inflationary challenges. Such global or regional economic and political conditions adversely affect demand for the Company's products. These conditions also have an impact on the Company's suppliers, contract manufacturers, logistics providers, and distributors, causing volatility in cost of materials and shipping and transportation rates, and as a result impacting the pricing of the Company's products. Price increases may not successfully offset cost increases or may cause the Company to lose market share and in turn adversely impact the Company's results of operations. While global supply chain challenges have improved since the second quarter of fiscal year 2023, including logistics costs and shipping lead times, the increase of COVID-19 infections in China during the third quarter of fiscal year 2023 causes uncertainty in supply availability. If macroeconomic and geopolitical conditions and COVID-19 related factors do not improve or worsen, the Company's results of operations will continue to be adversely impacted. Recent Accounting Pronouncements Adopted In October 2021, the Financial Accounting Standard Board issued ASU 2021-08, "Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers " (ASU 2021-08). The update requires an acquirer in a business combination to recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Accounting Standards Codification ("ASC") 606, Revenue from Contracts with Customers , as if it had originated the contracts. The standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. The Company early adopted the standard effective April 1, 2022 and applies the standard prospectively to business combinations that occurred on or after April 1, 2022. The adoption of ASU 2021-08 did not have a material impact on the Company's condensed consolidated financial statements.

Net Income Per Share

Net Income Per Share	9 Months Ended
Net Income Per Share	Dec. 31, 2022
Earnings Per Share [Abstract]
Net Income Per Share	Net Income Per Share The following table summarizes the computations of basic and diluted net income per share for the three and nine months ended December 31, 2022 and 2021 (in thousands, except per share amounts): Three Months Ended Nine Months Ended 2022 2021 2022 2021 Net income $ 140,153 $ 210,011 $ 323,080 $ 536,308 Shares used in net income per share computation: Weighted average shares outstanding - basic 161,244 167,090 163,042 167,953 Effect of potentially dilutive equivalent shares 1,285 2,617 1,385 3,074 Weighted average shares outstanding - diluted 162,529 169,707 164,427 171,027 Net income per share: Basic $ 0.87 $ 1.26 $ 1.98 $ 3.19 Diluted $ 0.86 $ 1.24 $ 1.96 $ 3.14 Share equivalents attributable to outstanding stock options, restricted stock units ("RSUs") and employee share purchase plans ("ESPP") totalin g 1.6 million and 0.8 million for the three months ended December 31, 2022 and 2021, respectively, and 2.0 million and 0.9 million for the nine months ended December 31, 2022 and 2021, respectively, were excluded from the calculation of diluted net income per share because their effect would have been anti-dilutive. A small number of performance-based awards were not included in the calculation because all necessary conditions had not been satisfied by the end of the respective period, and those shares were not issuable if the end of the reporting period were the end of the performance contingency period.

Employee Benefit Plans

Employee Benefit Plans	9 Months Ended
Employee Benefit Plans	Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]
Employee Benefit Plans	Employee Benefit Plans Employee Share Purchase Plans and Stock Incentive Plans As of December 31, 2022, the Company offers the 2006 Employee Share Purchase Plan (Non-U.S.), as amended and restated ("2006 ESPP"), the 1996 Employee Share Purchase Plan (U.S.), as amended and restated ("1996 ESPP"), and the 2006 Stock Incentive Plan ("2006 Plan") as amended and restated. Shares issued to employees as a result of purchases or exercises under these plans are generally issued from shares held in treasury stock. The following table summarizes the share-based compensation expense and total income tax benefit recognized for share-based awards for the three and nine months ended December 31, 2022 and 2021 (in thousands): Three Months Ended Nine Months Ended 2022 2021 2022 2021 Cost of goods sold $ 1,324 $ 1,782 $ 4,228 $ 5,253 Marketing and selling 8,014 10,699 25,240 28,987 Research and development 2,756 4,510 11,568 14,295 General and administrative 3,711 7,801 10,704 23,930 Total share-based compensation expense 15,805 24,792 51,740 72,465 Income tax benefit (3,276) (3,581) (7,496) (23,460) Total share-based compensation expense, net of income tax benefit $ 12,529 $ 21,211 $ 44,244 $ 49,005 The income tax benefit in the respective periods primarily consisted of tax benefits related to the share-based compensation expense for the period and direct tax benefit realized, including net excess tax benefits recognized from share-based awards vested or exercised during the period. Share-based compensation costs capitalized as part of inventory were $1.3 million and $1.1 million for the three months ended December 31, 2022 and 2021, respectively, and $4.4 million and $4.1 million for the nine months ended December 31, 2022 and 2021, respectively. Defined Benefit Plans Certain of the Company’s subsidiaries sponsor defined benefit pension plans or non-retirement post-employment benefits covering substantially all of their employees. Benefits are provided based on employees’ years of service and earnings, or in accordance with applicable employee benefit regulations. The Company’s practice is to fund amounts sufficient to meet the requirements set forth in the applicable employee benefit and tax regulations. The costs of $2.7 million and $3.4 million recorded for the three months ended December 31, 2022 and 2021, respectively, and $8.3 million and $10.0 million for the nine months ended December 31, 2022 and 2021, respectively, were primarily related to service costs.

Income Taxes

Income Taxes	9 Months Ended
Income Taxes	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The Company is incorporated in Switzerland but operates in various countries with differing tax laws and rates. Further, a portion of the Company’s income before taxes and the provision for (benefit from) income taxes are generated outside of Switzerland. The income tax provision for the three and nine months ended December 31, 2022 was $42.7 million and $87.8 million, based on an effective income tax rate of 23.3% and 21.4% of pre-tax income, respectively. The income tax provision for the same periods ended December 30, 2021 was $49.3 million and $107.8 million, based on an effective income tax rate of 19.0% and 16.7% of pre-tax income, respectively. The change in the effective income tax rate for the three and nine months ended December 31, 2022 was primarily due to the mix of income and losses in the various tax jurisdictions in which the Company operates. There were discrete tax benefits of $0.2 million and $1.4 million from the recognition of excess tax benefits in the United States in the three and nine months ended December 31, 2022, respectively. In addition, there were discrete tax benefits of $1.7 million and $3.2 million from the reversal of uncertain tax positions from the expiration of statutes of limitations, respectively, in the three and nine month period ended December 31, 2022. The change in the effective income tax rate for the three and nine months ended December 31, 2021 was primarily due to the mix of income and losses in the various tax jurisdictions in which the Company operates. There were discrete tax benefits of $0.8 million and $15.2 million from the recognition of excess tax benefits in the United States in the three and nine months ended December 31, 2021, respectively. Furthermore, there were discrete tax benefits of $1.3 million and $2.8 million from the reversal of uncertain tax positions from the expiration of statutes of limitations, respectively, in the three and nine month period ended December 31, 2021. As of December 31, 2022 and March 31, 2022, the total amount of unrecognized tax benefits due to uncertain tax positions was $184.0 million and $176.0 million, respectively, all of which would affect the effective income tax rate if recognized. As of December 31, 2022 and March 31, 2022, the Company had $117.6 million and $83.4 million, respectively, in non-current income taxes payable including interest and penalties, related to the Company's income tax liability for uncertain tax positions. The Company recognizes interest and penalties related to unrecognized tax positions in the income tax provision. As of December 31, 2022 and March 31, 2022, the Company had $5.2 million and $3.6 million, respectively, of accrued interest and penalties related to uncertain tax positions in non-current income taxes payable. Although the Company has adequately provided for uncertain tax positions, the provisions related to these positions may change as revised estimates are made or the underlying matters are settled or otherwise resolved. During fiscal year 2023, the Company continues to review its tax positions and provide for or reverse unrecognized tax benefits as they arise. During the next twelve months, it is reasonably possible that the amount of unrecognized tax benefits could increase or decrease significantly due to changes in tax law in various jurisdictions, new tax audits and changes in the U.S. dollar as compared to other currencies. Excluding these factors, uncertain tax

Balance Sheet Components

Balance Sheet Components	9 Months Ended
Balance Sheet Components	Dec. 31, 2022
Balance Sheet Related Disclosures [Abstract]
Balance Sheet Components	Balance Sheet Components The following table presents the components of certain balance sheet asset amounts (in thousands): December 31, 2022 March 31, 2022 Accounts receivable, net: Accounts receivable $ 1,121,377 $ 964,766 Allowance for doubtful accounts — (2,212) Allowance for sales returns (14,021) (12,321) Allowance for cooperative marketing arrangements (62,734) (56,372) Allowance for customer incentive programs (114,160) (97,460) Allowance for pricing programs (128,027) (120,797) $ 802,435 $ 675,604 Inventories: Raw materials $ 202,798 $ 226,155 Finished goods 594,897 706,969 $ 797,695 $ 933,124 Other current assets: Value-added tax ("VAT") receivables $ 51,681 $ 58,850 Prepaid expenses and other assets 73,407 76,628 $ 125,088 $ 135,478 Property, plant and equipment, net: Property, plant and equipment $ 496,830 $ 459,413 Less: accumulated depreciation and amortization (378,647) (349,606) $ 118,183 $ 109,807 Other assets: Deferred tax assets $ 190,558 $ 193,629 Investments in privately held companies 32,600 43,068 Right-of-use assets 69,953 40,661 Investments for deferred compensation plan 27,665 28,431 Other assets 15,103 14,933 $ 335,879 $ 320,722 The following table presents the components of certain balance sheet liability amounts (in thousands): December 31, 2022 March 31, 2022 Accrued and other current liabilities: Accrued customer marketing, pricing and incentive programs $ 238,518 $ 232,393 Accrued personnel expenses 113,486 165,090 Accrued sales return liability 42,743 40,507 Warranty accrual 29,999 32,987 VAT payable 34,149 39,602 Income taxes payable 17,839 35,355 Accrued payables - non-inventory 18,398 26,722 Operating lease liabilities 11,577 13,690 Contingent consideration 6,368 8,042 Other current liabilities 192,492 190,460 $ 705,569 $ 784,848 Other non-current liabilities: Employee benefit plan obligations $ 49,082 $ 50,741 Operating lease liabilities 61,414 28,207 Obligation for deferred compensation plan 27,665 28,431 Warranty accrual 12,632 13,232 Deferred tax liabilities 3,500 1,962 Contingent consideration 245 4,217 Other non-current liabilities 11,377 5,343 $ 165,915 $ 132,133

Fair Value Measurements

Fair Value Measurements	9 Months Ended
Fair Value Measurements	Dec. 31, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements Fair Value Measurements The Company considers fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. The Company utilizes the following three-level fair value hierarchy to establish the priorities of the inputs used to measure fair value: • Level 1 — Quoted prices in active markets for identical assets or liabilities. • Level 2 — Observable inputs other than quoted market prices included in Level 1, such as: quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data. • Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. This includes certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs. The following table presents the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis, excluding assets related to the Company’s defined benefit pension plans, classified by the level within the fair value hierarchy (in thousands): December 31, 2022 March 31, 2022 Level 1 Level 2 Level 3 Level 1 Level 2 Level 3 Assets: Cash equivalents $ 603,163 $ — $ — $ 762,055 $ — $ — Investments for deferred compensation plan included in other assets: Cash $ 10 $ — $ — $ 108 $ — $ — Common stock 705 — — 2,329 — — Money market funds 9,728 — — 6,765 — — Mutual funds 17,222 — — 19,229 — — Total investments for deferred compensation plan $ 27,665 $ — $ — $ 28,431 $ — $ — Currency derivative assets $ — $ 668 $ — $ — $ 1,517 $ — Liabilities: Contingent consideration included in accrued and other current liabilities $ — $ — $ 6,368 $ — $ — $ 8,042 Contingent consideration included in other non-current liabilities $ — $ — $ — $ — $ — $ 3,971 Currency derivative liabilities $ — $ 3,519 $ — $ — $ 165 $ — Contingent Consideration for Business Acquisitions The following table summarizes the change in the fair value of the Company's contingent consideration balance during the nine months ended December 31, 2022 and 2021 (in thousands): Nine Months Ended 2022 2021 Beginning of the period $ 12,259 $ 6,967 Fair value of contingent consideration upon acquisition (1) 2,151 9,973 Change in fair value of contingent consideration — (3,509) Settlement of contingent consideration (5,954) (880) Effect of foreign currency exchange rate changes (1,843) — End of the period $ 6,613 $ 12,551 (1) Represents the contingent consideration related to the technology acquisitions during the periods. The contingent consideration arising from the technology acquisition on May 19, 2021, represents the future potential earn-out payments of up to $10.0 million payable in cash only upon the achievement of three technical development milestones required to be completed as of December 31, 2021, June 30, 2022, and June 30, 2023. The fair value of the contingent consideration as of the acquisition date was $10.0 million, which was determined using a probability-weighted expected payment model and discounted at the estimated cost of debt. During the third quarter of fiscal year 2022, $0.9 million of the contingent consideration was released from other current liabilities upon cash settlement of the contingent consideration for the first technical development milestone. During the second quarter of fiscal year 2023, the Company paid $4.0 million for the contingent consideration related to the second technical development milestone. The contingent consideration arising from the Mevo Acquisition on February 17, 2021 represents the future potential earn-out payments of up to $17.0 million payable in cash only upon the achievement of certain net sales for the period from December 26, 2020 to December 31, 2021. As of March 31, 2021 the fair value of the contingent consideration was $3.4 million. A s of December 31, 2021, the fair value of the contingent consideration was released from other current liabilities as the net sales milestone was not achieved upon completion of the earn-out period. The contingent consideration arising from the technology acquisition on January 4, 2021, represents the future potential earn-out payments of up to $3.0 million payable in cash upon the achievement of two technical development milestones required to be completed as of December 31, 2021 and March 31, 2022. The fair value of the contingent amount was determined using a probability-weighted expected payment model and discounted at the estimated cost of debt. During the second quarter of fiscal year 2023, the Company paid $2.0 million for the contingent consideration related to the first technical development milestone. The Company expects to pay the remaining $1.0 million for the second technical development milestone within next twelve months. Although the estimate of contingent consideration is based on management’s best knowledge of current events, the estimate could change significantly from period to period. Actual results that differ from the assumptions used and any changes to the significant assumptions and unobservable inputs used could have an impact on future results of operations. Investment for Deferred Compensation Plan The marketable securities for the Company's deferred compensation plan were recorded at a fair value of $27.7 million and $28.4 million, as of December 31, 2022 and March 31, 2022, respectively, based on quoted market prices. Quoted market prices are observable inputs that are classified as Level 1 within the fair value hierarchy. Unrealized gains (losses) related to marketable securities for the three and nine months ended December 31, 2022 and 2021 were not material and were included in other income (expense), net in the Company's condensed consolidated statements of operations. Equity Method Investments The Company has certain non-marketable investments included in other assets that are accounted for as equity method investments, with a carrying value of $21.3 million and $40.2 million as of December 31, 2022 and March 31, 2022, respectively. Gains (losses) related to equity method investments for the three and nine months ended December 31, 2022 and 2021 were not material and are included in other income (expense), net in the Company's condensed consolidated statements of operations. During the nine months ended December 31, 2022 , the Company recorded an impairment charge, before tax, of $21.4 million for one of its equity method investments as it was determined that the carrying value of the investment was not recoverable. The impairment charge is included in other income (expense), net in the Company's condensed consolidated statement of operations for the nine months ended December 31, 2022. There was no impairment of equity method investments during the three months ended December 31, 2022 and 2021 and the nine months ended December 31, 2021. Other Assets Measured at Fair Value on a Nonrecurring Basis Financial Assets. The Company has certain equity investments without readily determinable fair values due to the absence of quoted market prices, the inherent lack of liquidity, and the fact that inputs used to measure fair value are unobservable and require management's judgment. When certain events or circumstances indicate that impairment may exist, the Company revalues the investments using various assumptions, including the financial metrics and ratios of comparable public companies. The carrying value is also adjusted for observable price changes with the same or similar security from the same issuer. The amount of these equity investments without readily determinable fair value included in other assets was $10.9 million and $2.9 million as of December 31, 2022 and March 31, 2022, respectively. During the nine months ended December 31, 2022, the Company recorded an unrealized gain, before tax, of $6.9 million for its investment in a private company as a result of observable price changes for similar securities issued by this company (level 2 fair value measurement). There was no impairment of these financial assets during the three and nine months ended December 31, 2022 and 2021, other than an immaterial impairment charge related to one of the Company’s investments without readily determinable fair value recorded during the second quarter of fiscal year 2023 . Non-Financial Assets. Goodwill, intangible assets, and property, plant and equipment, are not required to be measured at fair value on a recurring basis. However, if the Company is required to evaluate these non-financial assets for impairment, whether due to certain triggering events or because of the required annual impairment test, and a resulting impairment is recorded to reduce the carrying value to the fair value, the non-financial assets are measured at fair value during such period. There was no impairment of non-financial assets during the three and nine months ended December 31, 2022. During the three and nine months ended December 31, 2021, the Company recorded impairment charges of $7.0 million for the Jaybird-related

Derivative Financial Instrument

Derivative Financial Instruments	9 Months Ended
Derivative Financial Instruments	Dec. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	Derivative Financial Instruments Under certain agreements with the respective counterparties to the Company’s derivative contracts, subject to applicable requirements, the Company is allowed to net settle transactions of the same type with a single net amount payable by one party to the other. However, the Company presents its derivative assets and derivative liabilities on a gross basis in other current assets and accrued and other current liabilities, respectively, on the condensed consolidated balance sheets as of December 31, 2022 and March 31, 2022. See Note 6 for the fair values of the Company’s derivative instruments as of December 31, 2022 and March 31, 2022. Cash Flow Hedges The Company enters into cash flow hedge contracts to protect against exchange rate exposure of forecasted inventory purchases. These hedging contracts mature within four months. Gains and losses in the fair value of the effective portion of the hedges are deferred as a component of accumulated other comprehensive loss until the hedged inventory purchases are sold, at which time the gains or losses are reclassified to cost of goods sold. Cash flows from such hedges are classified as operating activities in the condensed consolidated statements of cash flows. Hedging relationships are discontinued when hedging contract is no longer eligible for hedge accounting, or is sold, terminated or exercised, or when the Company removes hedge designation for the contract. Gains and losses in the fair value of the effective portion of the discontinued hedges continue to be reported in accumulated other comprehensive loss until the hedged inventory purchases are sold, unless it is probable that the forecasted inventory purchases will not occur by the end of the originally specified time period or within an additional two-month period of time thereafter. The notional amounts of foreign currency exchange forward contracts outstanding related to forecasted inventory purchases were $111.7 million and $125.4 million as of December 31, 2022 and March 31, 2022, respectively. The Company had $4.7 million of net losses related to its cash flow hedges included in accumulated other comprehensive loss as of December 31, 2022, which will be reclassified into earnings within the next twelve months. The following table presents the amounts of gain (loss) on the Company’s derivative instruments designated as hedging instruments for the three and nine months ended December 31, 2022 and 2021 and their locations on its condensed consolidated statements of operations and condensed consolidated statements of comprehensive income (in thousands): Three Months Ended Amount of Gain (Loss) Amount of Gain 2022 2021 2022 2021 Cash flow hedges $ (6,325) $ 1,061 $ (4,728) $ (3,200) Nine Months Ended Amount of Gain Amount of Gain 2022 2021 2022 2021 Cash flow hedges $ 5,239 $ 3,723 $ (11,766) $ (5,108) The Company presents the earnings impact from forward points in the same line item that is used to present the earnings impact of the hedged item, i.e. cost of goods sold, for hedging forecasted inventory purchases and such amount is not material for all periods presented. Other Derivatives The Company also enters into foreign currency exchange forward and swap contracts to reduce the short-term effects of currency exchange rate fluctuations on certain receivables or payables denominated in currencies other than the functional currencies of its subsidiaries. These contracts generally mature within a month. The primary risk managed by using forward and swap contracts is the currency exchange rate risk. The gains or losses on these contracts are not material and included i n other income (expense), net in the condensed consolidated statements of operations based on the changes in fair value. The notional amounts of these contracts outstanding as of December 31, 2022 and March 31, 2022 were $217.6 million and $226.5 million, respectively. Foreign currency exchange forward and swap contracts outstanding as of December 31, 2022 primarily consist of contracts in Japanese Yen, Brazilian Real, Canadian Dollar, and Australian Dollar to be se ttled at future dates at pre-determined exchange rates.

Goodwill and Other Intangible A

Goodwill and Other Intangible Assets	9 Months Ended
Goodwill and Other Intangible Assets	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Other Intangible Assets	Goodwill and Other Intangible Assets The Company conducts its impairment analysis of goodwill annually at December 31 and as necessary, if changes in facts and circumstances indicate that it is more likely than not that the fair value of the Company’s reporting unit may be less than its carrying amount. The Company conducted its annual impairment analysis of goodwill as of December 31, 2022 by performing a qualitative assessment and concluded that it was more likely than not that the fair value of its reporting unit exceeds its carrying amount. In assessing the qualitative factors, the Company considered the impact of change in industry and competitive environment, the Company's market capitalization and budgeted-to-actual revenue performance for the last twelve months. The following table summarizes the activities in the Company’s goodwill balance (in thousands): As of March 31, 2022 $ 448,175 Acquisitions 7,976 Effects of foreign currency translation (1,680) As of December 31, 2022 $ 454,471 The Company's acquired intangible assets were as follows (in thousands): December 31, 2022 March 31, 2022 Gross Carrying Amount Accumulated Net Carrying Amount Gross Carrying Amount Accumulated Net Carrying Amount Trademark and trade names $ 36,790 $ (25,787) $ 11,003 $ 36,790 $ (22,295) $ 14,495 Developed technology 123,530 (93,058) 30,472 119,407 (83,540) 35,867 Customer contracts/relationships 71,110 (46,026) 25,084 71,110 (40,971) 30,139 In-process R&D 3,526 — 3,526 3,826 — 3,826 Effects of foreign currency translation (1,077) 356 (721) (634) 86 (548) Total $ 233,879 $ (164,515) $ 69,364 $ 230,499 $ (146,720) $ 83,779

Financing Arrangements

Financing Arrangements	9 Months Ended
Financing Arrangements	Dec. 31, 2022
Debt Disclosure [Abstract]
Financing Arrangements	Financing Arrangements The Company had several uncommitted, unsecured bank lines of credit aggregating $179.2 million and $195.0 million as of December 31, 2022 and March 31, 2022, respectively. There are no financial covenants under these lines of credit with which the Company must comply. As of December 31, 2022 and March 31, 2022, the Company had outstanding bank guarantees of $11.6 million and $25.5 million, respectively, under these lines of credit. There was no borrowing outstanding under these lines of credit as of December 31, 2022 or March 31, 2022.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
Commitments and Contingencies	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Product Warranties Changes in the Company’s warranty liability for the three and nine months ended December 31, 2022 and 2021 were as follows (in thousands): Three Months Ended Nine Months Ended 2022 2021 2022 2021 Beginning of the period $ 41,960 $ 49,173 $ 46,219 $ 48,832 Provision 8,920 6,962 23,440 23,503 Settlements (8,979) (8,056) (26,358) (24,219) Effects of foreign currency translation 730 (144) (670) (181) End of the period $ 42,631 $ 47,935 $ 42,631 $ 47,935 Indemnifications The Company indemnifies certain of its suppliers and customers for losses arising from matters such as intellectual property disputes and product safety defects, subject to certain restrictions. The scope of these indemnities varies, but in some instances, includes indemnification for damages and expenses, including reasonable attorneys’ fees. As of December 31, 2022, no material amounts have been accrued for these indemnification provisions. The Company does not believe, based on historical experience and information currently available, that it is probable that any material amounts will be required to be paid under its indemnification arrangements. The Company also indemnifies its current and former directors and certain of its current and former officers. Certain costs incurred for providing such indemnification may be recoverable under various insurance policies. The Company is unable to reasonably estimate the maximum amount that could be payable under these arrangements because these exposures are not limited, the obligations are conditional in nature and the facts and circumstances involved in any situation that might arise are variable. Legal Proceedings From time to time the Company is involved in claims and legal proceedings that arise in the ordinary course of its business. The Company is currently subject to several such claims and a small number of legal proceedings. The Company believes that these matters lack merit and intends to vigorously defend against them. Based on currently available information, the Company does not believe that resolution of pending matters will have a material adverse effect on its financial condition, cash flows or results of operations. However, litigation is subject to inherent uncertainties, and there can be no assurances that the Company's defenses will be successful or that any such lawsuit or claim would not have a material adverse impact on the Company's business, financial condition, cash flows and results of operations in a particular period. Any claims or proceedings against the Company, whether meritorious or not, can have an adverse impact because of defense costs, diversion of management and operational resources, negative publicity and other factors. Any failure to obtain a necessary license or other rights, or litigation arising out of intellectual property claims, could adversely affect the Company's business.

Shareholders' Equity

Shareholders' Equity	9 Months Ended
Shareholders' Equity	Dec. 31, 2022
Stockholders' Equity Note [Abstract]
Shareholders' Equity	Shareholders’ Equity Share Repurchases In May 2020, the Company's Board of Directors approved the 2020 share repurchase program, which authorized the Company to use up to $250.0 million to purchase up to 17.3 million of Logitech shares. Shares may be repurchased from time to time on the open market, through block trades or otherwise. Purchases may be started or stopped at any time without prior notice depending on market conditions and other factors. In April 2021, the Company's Board of Directors approved an increase of $750.0 million of the 2020 share repurchase program, to an aggregate amount of $1.0 billion. The Swiss Takeover Board approved this increase and it became effective on May 21, 2021. In July 2022, the Company’s Board of Directors approved an increase of $500 million to the 2020 share repurchase program, to an aggregate amount of up to $1.5 billion to purchase up to 17.3 million of Logitech shares. The Swiss Takeover Board approved this increase and it became effective on August 19, 2022. As of December 31, 2022 , $596.3 m illion was available for repurchase under the 2020 repurchase program. The 2020 share repurchase program is expected to remain in effect for a period of three years through July 27, 2023. Dividends During the nine months ended December 31, 2022, the Company declared and paid cash dividends of CHF 0.96 (USD equivalent of $1.00 based on the exchange rate on the date of declaration) per share, totaling $162.7 million on the Company's outstanding shares. During the nine months ended December 31, 2021, the Company declared and paid cash dividends of CHF 0.87 (USD equivalent of $0.95 based on the exchange rate on the date of declaration) per share, totaling $159.4 million on the Company's outstanding shares. Any future dividends will be subject to approval of the Company's shareholders. Accumulated Other Comprehensive Income (Loss) The accumulated other comprehensive income (loss) was as follows (in thousands): Cumulative Translation Adjustment Defined Benefit Plans Deferred Hedging Gains (Losses) Total March 31, 2022 $ (102,461) $ (3,495) $ 1,833 $ (104,123) Other comprehensive income (loss) (5,988) (330) (6,527) (12,845) December 31, 2022 $ (108,449) $ (3,825) $ (4,694) $ (116,968)

Segment Information

Segment Information	9 Months Ended
Segment Information	Dec. 31, 2022
Segment Reporting [Abstract]
Segment Information	Segment Information The Company operates in a single operating segment that encompasses the design, manufacturing and marketing of peripherals for PCs, tablets and other digital platforms. Operating performance measures are provided directly to the Company's CEO, who is considered to be the Company’s Chief Operating Decision Maker. The CEO periodically reviews information such as sales and adjusted operating income (loss) to make business decisions. These operating performance measures do not include restructuring charges, net, share-based compensation expense, amortization and impairment of intangible assets, acquisition-related costs and change in fair value of contingent consideration from business acquisitions. Sales by product categories and sales channels, excluding intercompany transactions, for the three and nine months ended December 31, 2022 and 2021 were as follows (in thousands): Three Months Ended Nine Months Ended 2022 2021 2022 2021 Pointing Devices $ 199,106 $ 231,090 $ 567,589 $ 602,982 Keyboards & Combos 220,059 281,608 648,632 736,237 PC Webcams 58,481 115,115 178,033 319,504 Tablet & Other Accessories 65,157 82,859 185,945 242,932 Gaming (1) 391,975 469,282 972,457 1,135,456 Video Collaboration 226,374 287,187 708,796 753,725 Mobile Speakers 38,321 56,748 99,826 124,724 Audio & Wearables 69,104 104,280 211,821 318,965 Other (2) 1,348 4,613 5,642 16,582 Total Sales $ 1,269,925 $ 1,632,782 $ 3,578,741 $ 4,251,107 (1) Gaming includes streaming services revenue generated by Streamlabs. (2) Other includes Smart Home. Sales by geographic region (based on the customers’ locations) for the three and nine months ended December 31, 2022 and 2021 were as follows (in thousands): Three Months Ended Nine Months Ended 2022 2021 2022 2021 Americas $ 513,835 $ 674,393 $ 1,508,318 $ 1,828,474 EMEA 428,532 552,133 1,016,187 1,309,542 Asia Pacific 327,558 406,256 1,054,236 1,113,091 Total sales $ 1,269,925 $ 1,632,782 $ 3,578,741 $ 4,251,107 Revenue from sales to customers in the United States, Germany and China each represented 10% or more of the total consolidated sales for each of the periods presented herein. No other countries represented 10% or more of the Company’s total consolidated sales for the periods presented herein. Switzerland, the Company’s home domicile, represented 4% and 3% of the Company's total consolidated sales for the three months ended December 31, 2022 and 2021, respectively, and 3% for each of the nine months ended December 31, 2022 and 2021. Three customers of the Company each represented 10% or more of the total consolidated gross sales for each of the three and nine months ended December 31, 2022. Two customers of the Company each represented 10% or more of the total consolidated sales for each of the three and nine months ended December 31, 2021. Property, plant and equipment, net (excluding software) and right-of-use assets by geographic region were as follows (in thousands): December 31, 2022 March 31, 2022 Americas $ 49,447 $ 22,578 EMEA 38,380 23,830 Asia Pacific 78,458 87,265 Total $ 166,285 $ 133,673 Property, plant and equipment, net (excluding software) and right-of-use assets in the United States, China, and Ireland were $48.9 million, $56.8 million, and $17.6 million, respectively, as of December 31, 2022, and $21.7 million, $66.8 million, and $0.9 million respectively, as of March 31, 2022. Property, plant and equipment, net (excluding software) and right-of-use assets in Switzerland, the Company’s country of incorporation, were $12.9 million and $13.6 million as of December 31, 2022 and March 31, 2022, respectively. No other countries

Restructuring

Restructuring	9 Months Ended
Restructuring	Dec. 31, 2022
Restructuring and Related Activities [Abstract]
Restructuring	Restructuring During the second quarter of fiscal year 2023, the Company initiated a restructuring plan to realign its business group and engineering structure with its go-to-market strategy to more effectively compete within the enterprise market and to better serve end-users. As a result, the Company recorded pre-tax restructuring charges of $5.7 million and $16.5 million for the three and nine months ended December 31, 2022, respectively, which are included in restructuring charges, net in the condensed consolidated statements of operations. The restructuring charges of $5.7 million for the three months ended December 31, 2022 primarily include contract termination and other costs. The restructuring charges for the nine months ended December 31, 2022 include $11.3 million employee severance and other termination benefits and $5.2 million contract termination and other costs. As of December 31, 2022, restructuring liabilities of $8.3 million related to this restructuring plan are included in accrued and other current liabilities in the condensed consolidated balance sheet, which include $3.6 million related to employee severance and other termination benefits and $4.7 million related to contract termination and other costs. The Company expects to substantially complete this restructuring plan within the next nine months. During the third quarter of fiscal year 2022, as part of the Company's strategic review, the Company decided to cease future product launches under the Jaybird brand within the Audio & Wearables product category. As a result, the Company recorded $7.6 million in cost of goods sold related to write-offs for excess inventories, $7.0 million impairment to the intangible assets acquired as part of the Jaybird acquisition (see Note 8), and $1.8 million in restructuring charges, net, primarily related to production cancellation costs, for the three and nine months ended December 31, 2021. This restructuring plan has been substantially completed.

The Company and Summary of Si_2

The Company and Summary of Significant Accounting Policies and Estimates (Policies)	9 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The condensed consolidated financial statements include the accounts of Logitech and its subsidiaries. All intercompany balances and transactions have been eliminated. The condensed consolidated financial statements are presented in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial information and therefore do not include all the information required by U.S. GAAP for complete financial statements. The condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements for the fiscal year ended March 31, 2022, included in its Annual Report on Form 10-K filed with the Securities and Exchange Commission ("SEC") on May 18, 2022. In the opinion of management, these condensed consolidated financial statements include all adjustments, consisting of only normal and recurring adjustments, necessary and in all material aspects, for a fair statement of the results of operations, comprehensive income, financial position, cash flows and changes in shareholders' equity for the periods presented. Operating results for the three and nine months ended December 31, 2022 are not necessarily indicative of the results that may be expected for the fiscal year ending March 31, 2023, or any future periods.
Changes in Significant Accounting Policies and Recent Accounting Pronouncements Adopted	Changes in Significant Accounting Policies Other than the recent accounting pronouncements adopted and discussed below under Recent Accounting Pronouncements Adopted , there have bee n no material changes in the Company’s significant accounting policies during the nine months ended December 31, 2022 compared with the significant accounting policies described in its Annual Report on Form 10-K for the fiscal year ended March 31, 2022. Recent Accounting Pronouncements Adopted In October 2021, the Financial Accounting Standard Board issued ASU 2021-08, "Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers " (ASU 2021-08). The update requires an acquirer in a business combination to recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Accounting Standards Codification ("ASC") 606, Revenue from Contracts with Customers , as if it had originated the contracts. The standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. The Company early adopted the standard effective April 1, 2022 and applies the standard prospectively to business combinations that occurred on or after April 1, 2022. The adoption of ASU 2021-08 did not have a material impact on the Company's condensed consolidated financial statements.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and various other assumptions believed to be reasonable. Significant estimates and assumptions made by management involve the fair value of goodwill and intangible assets acquired from business acquisitions, contingent consideration for a business acquisition and periodic reassessment of its fair value, valuation of investment in privately held companies classified under Level 3 fair value hierarchy, pension obligations, accruals for customer incentives, cooperative marketing, and pricing programs and related breakage when appropriate, inventory valuation, share-based compensation expense, uncertain tax positions, and valuation allowances for deferred tax assets. Although these
Risks and Uncertainties	Risks and Uncertainties Impacts of Macroeconomic and Geopolitical Conditions and Other Factors on the Company's Business In March 2020, the World Health Organization declared the outbreak of COVID-19 as a pandemic, which continues to spread throughout the world. The COVID-19 pandemic resulted in industry-wide global supply chain challenges, including manufacturing, transportation and logistics. The Company purchases certain products and key components from a limited number of sources, and depends on the supply chain, including freight, to receive components, transport finished goods and deliver the Company's products across the world. More recently, the Company has also been impacted by adverse macroeconomic and geopolitical conditions. These conditions include but are not limited to inflation, foreign currency fluctuations, and slowdown of economic activity around the world, in part due to rising interest rates, and lower consumer and enterprise spending . In addition, the war in Ukraine increased global supply chain, logistics, and inflationary challenges. Such global or regional economic and political conditions adversely affect demand for the Company's products. These conditions also have an impact on the Company's suppliers, contract manufacturers, logistics providers, and distributors, causing volatility in cost of materials and shipping and transportation rates, and as a result impacting the pricing of the Company's products. Price increases may not successfully offset cost increases or may cause the Company to lose market share and in turn adversely impact the Company's results of operations.

Net Income Per Share (Tables)

Net Income Per Share (Tables)	9 Months Ended
Net Income Per Share (Tables)	Dec. 31, 2022
Earnings Per Share [Abstract]
Schedule of Computations of Basic and Diluted Net Income Per Share	The following table summarizes the computations of basic and diluted net income per share for the three and nine months ended December 31, 2022 and 2021 (in thousands, except per share amounts): Three Months Ended Nine Months Ended 2022 2021 2022 2021 Net income $ 140,153 $ 210,011 $ 323,080 $ 536,308 Shares used in net income per share computation: Weighted average shares outstanding - basic 161,244 167,090 163,042 167,953 Effect of potentially dilutive equivalent shares 1,285 2,617 1,385 3,074 Weighted average shares outstanding - diluted 162,529 169,707 164,427 171,027 Net income per share: Basic $ 0.87 $ 1.26 $ 1.98 $ 3.19 Diluted $ 0.86 $ 1.24 $ 1.96 $ 3.14

Employee Benefit Plans (Tables)

Employee Benefit Plans (Tables)	9 Months Ended
Employee Benefit Plans (Tables)	Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]
Summary of Share-based Compensation Expenses and Related Tax Benefits Recognized	The following table summarizes the share-based compensation expense and total income tax benefit recognized for share-based awards for the three and nine months ended December 31, 2022 and 2021 (in thousands): Three Months Ended Nine Months Ended 2022 2021 2022 2021 Cost of goods sold $ 1,324 $ 1,782 $ 4,228 $ 5,253 Marketing and selling 8,014 10,699 25,240 28,987 Research and development 2,756 4,510 11,568 14,295 General and administrative 3,711 7,801 10,704 23,930 Total share-based compensation expense 15,805 24,792 51,740 72,465 Income tax benefit (3,276) (3,581) (7,496) (23,460) Total share-based compensation expense, net of income tax benefit $ 12,529 $ 21,211 $ 44,244 $ 49,005

Balance Sheet Components (Table

Balance Sheet Components (Tables)	9 Months Ended
Balance Sheet Components (Tables)	Dec. 31, 2022
Balance Sheet Related Disclosures [Abstract]
Schedule of Components of Certain Balance Sheet Asset Amounts	The following table presents the components of certain balance sheet asset amounts (in thousands): December 31, 2022 March 31, 2022 Accounts receivable, net: Accounts receivable $ 1,121,377 $ 964,766 Allowance for doubtful accounts — (2,212) Allowance for sales returns (14,021) (12,321) Allowance for cooperative marketing arrangements (62,734) (56,372) Allowance for customer incentive programs (114,160) (97,460) Allowance for pricing programs (128,027) (120,797) $ 802,435 $ 675,604 Inventories: Raw materials $ 202,798 $ 226,155 Finished goods 594,897 706,969 $ 797,695 $ 933,124 Other current assets: Value-added tax ("VAT") receivables $ 51,681 $ 58,850 Prepaid expenses and other assets 73,407 76,628 $ 125,088 $ 135,478 Property, plant and equipment, net: Property, plant and equipment $ 496,830 $ 459,413 Less: accumulated depreciation and amortization (378,647) (349,606) $ 118,183 $ 109,807 Other assets: Deferred tax assets $ 190,558 $ 193,629 Investments in privately held companies 32,600 43,068 Right-of-use assets 69,953 40,661 Investments for deferred compensation plan 27,665 28,431 Other assets 15,103 14,933 $ 335,879 $ 320,722
Schedule of Components of Certain Balance Sheet Liability Amounts	The following table presents the components of certain balance sheet liability amounts (in thousands): December 31, 2022 March 31, 2022 Accrued and other current liabilities: Accrued customer marketing, pricing and incentive programs $ 238,518 $ 232,393 Accrued personnel expenses 113,486 165,090 Accrued sales return liability 42,743 40,507 Warranty accrual 29,999 32,987 VAT payable 34,149 39,602 Income taxes payable 17,839 35,355 Accrued payables - non-inventory 18,398 26,722 Operating lease liabilities 11,577 13,690 Contingent consideration 6,368 8,042 Other current liabilities 192,492 190,460 $ 705,569 $ 784,848 Other non-current liabilities: Employee benefit plan obligations $ 49,082 $ 50,741 Operating lease liabilities 61,414 28,207 Obligation for deferred compensation plan 27,665 28,431 Warranty accrual 12,632 13,232 Deferred tax liabilities 3,500 1,962 Contingent consideration 245 4,217 Other non-current liabilities 11,377 5,343 $ 165,915 $ 132,133

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
Fair Value Measurements (Tables)	Dec. 31, 2022
Fair Value Disclosures [Abstract]
Schedule of Financial Assets and Liabilities, Classified by Level	The following table presents the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis, excluding assets related to the Company’s defined benefit pension plans, classified by the level within the fair value hierarchy (in thousands): December 31, 2022 March 31, 2022 Level 1 Level 2 Level 3 Level 1 Level 2 Level 3 Assets: Cash equivalents $ 603,163 $ — $ — $ 762,055 $ — $ — Investments for deferred compensation plan included in other assets: Cash $ 10 $ — $ — $ 108 $ — $ — Common stock 705 — — 2,329 — — Money market funds 9,728 — — 6,765 — — Mutual funds 17,222 — — 19,229 — — Total investments for deferred compensation plan $ 27,665 $ — $ — $ 28,431 $ — $ — Currency derivative assets $ — $ 668 $ — $ — $ 1,517 $ — Liabilities: Contingent consideration included in accrued and other current liabilities $ — $ — $ 6,368 $ — $ — $ 8,042 Contingent consideration included in other non-current liabilities $ — $ — $ — $ — $ — $ 3,971 Currency derivative liabilities $ — $ 3,519 $ — $ — $ 165 $ —
Schedule of Change in Fair Value of Contingent Consideration	The following table summarizes the change in the fair value of the Company's contingent consideration balance during the nine months ended December 31, 2022 and 2021 (in thousands): Nine Months Ended 2022 2021 Beginning of the period $ 12,259 $ 6,967 Fair value of contingent consideration upon acquisition (1) 2,151 9,973 Change in fair value of contingent consideration — (3,509) Settlement of contingent consideration (5,954) (880) Effect of foreign currency exchange rate changes (1,843) — End of the period $ 6,613 $ 12,551

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	9 Months Ended
Derivative Financial Instruments (Tables)	Dec. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Gains on Derivative Instruments	The following table presents the amounts of gain (loss) on the Company’s derivative instruments designated as hedging instruments for the three and nine months ended December 31, 2022 and 2021 and their locations on its condensed consolidated statements of operations and condensed consolidated statements of comprehensive income (in thousands): Three Months Ended Amount of Gain (Loss) Amount of Gain 2022 2021 2022 2021 Cash flow hedges $ (6,325) $ 1,061 $ (4,728) $ (3,200) Nine Months Ended Amount of Gain Amount of Gain 2022 2021 2022 2021 Cash flow hedges $ 5,239 $ 3,723 $ (11,766) $ (5,108)

Goodwill and Other Intangible_2

Goodwill and Other Intangible Assets (Tables)	9 Months Ended
Goodwill and Other Intangible Assets (Tables)	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Summary of Activity In Goodwill Balance	The following table summarizes the activities in the Company’s goodwill balance (in thousands): As of March 31, 2022 $ 448,175 Acquisitions 7,976 Effects of foreign currency translation (1,680) As of December 31, 2022 $ 454,471
Schedule of Intangible Assets Subject to Amortization	The Company's acquired intangible assets were as follows (in thousands): December 31, 2022 March 31, 2022 Gross Carrying Amount Accumulated Net Carrying Amount Gross Carrying Amount Accumulated Net Carrying Amount Trademark and trade names $ 36,790 $ (25,787) $ 11,003 $ 36,790 $ (22,295) $ 14,495 Developed technology 123,530 (93,058) 30,472 119,407 (83,540) 35,867 Customer contracts/relationships 71,110 (46,026) 25,084 71,110 (40,971) 30,139 In-process R&D 3,526 — 3,526 3,826 — 3,826 Effects of foreign currency translation (1,077) 356 (721) (634) 86 (548) Total $ 233,879 $ (164,515) $ 69,364 $ 230,499 $ (146,720) $ 83,779

Commitments and Contingencies (

Commitments and Contingencies (Tables)	9 Months Ended
Commitments and Contingencies (Tables)	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Schedule of Changes in Warranty Liability	Changes in the Company’s warranty liability for the three and nine months ended December 31, 2022 and 2021 were as follows (in thousands): Three Months Ended Nine Months Ended 2022 2021 2022 2021 Beginning of the period $ 41,960 $ 49,173 $ 46,219 $ 48,832 Provision 8,920 6,962 23,440 23,503 Settlements (8,979) (8,056) (26,358) (24,219) Effects of foreign currency translation 730 (144) (670) (181) End of the period $ 42,631 $ 47,935 $ 42,631 $ 47,935

Shareholders' Equity (Tables)

Shareholders' Equity (Tables)	9 Months Ended
Shareholders' Equity (Tables)	Dec. 31, 2022
Stockholders' Equity Note [Abstract]
Schedule of Components of Accumulated Other Comprehensive Income (Loss)	The accumulated other comprehensive income (loss) was as follows (in thousands): Cumulative Translation Adjustment Defined Benefit Plans Deferred Hedging Gains (Losses) Total March 31, 2022 $ (102,461) $ (3,495) $ 1,833 $ (104,123) Other comprehensive income (loss) (5,988) (330) (6,527) (12,845) December 31, 2022 $ (108,449) $ (3,825) $ (4,694) $ (116,968)

Segment Information (Tables)

Segment Information (Tables)	9 Months Ended
Segment Information (Tables)	Dec. 31, 2022
Segment Reporting [Abstract]
Schedule of Net Sales by Product Categories, Excluding Intercompany Transactions	Sales by product categories and sales channels, excluding intercompany transactions, for the three and nine months ended December 31, 2022 and 2021 were as follows (in thousands): Three Months Ended Nine Months Ended 2022 2021 2022 2021 Pointing Devices $ 199,106 $ 231,090 $ 567,589 $ 602,982 Keyboards & Combos 220,059 281,608 648,632 736,237 PC Webcams 58,481 115,115 178,033 319,504 Tablet & Other Accessories 65,157 82,859 185,945 242,932 Gaming (1) 391,975 469,282 972,457 1,135,456 Video Collaboration 226,374 287,187 708,796 753,725 Mobile Speakers 38,321 56,748 99,826 124,724 Audio & Wearables 69,104 104,280 211,821 318,965 Other (2) 1,348 4,613 5,642 16,582 Total Sales $ 1,269,925 $ 1,632,782 $ 3,578,741 $ 4,251,107 (1) Gaming includes streaming services revenue generated by Streamlabs. (2) Other includes Smart Home.
Schedule of Net Sales by Geographic Region	Sales by geographic region (based on the customers’ locations) for the three and nine months ended December 31, 2022 and 2021 were as follows (in thousands): Three Months Ended Nine Months Ended 2022 2021 2022 2021 Americas $ 513,835 $ 674,393 $ 1,508,318 $ 1,828,474 EMEA 428,532 552,133 1,016,187 1,309,542 Asia Pacific 327,558 406,256 1,054,236 1,113,091 Total sales $ 1,269,925 $ 1,632,782 $ 3,578,741 $ 4,251,107
Schedule of Long-Lived Assets by Geographic Region	Property, plant and equipment, net (excluding software) and right-of-use assets by geographic region were as follows (in thousands): December 31, 2022 March 31, 2022 Americas $ 49,447 $ 22,578 EMEA 38,380 23,830 Asia Pacific 78,458 87,265 Total $ 166,285 $ 133,673

Net Income Per Share - Computat

Net Income Per Share - Computations of Basic and Diluted Net Income Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Earnings Per Share [Abstract]
Net income	$ 140,153	$ 210,011	$ 323,080	$ 536,308
Net income	$ 140,153	$ 210,011	$ 323,080	$ 536,308
Shares used in net income per share computation:
Weighted average shares outstanding - basic (in shares)	161,244	167,090	163,042	167,953
Effect of potentially dilutive equivalent shares (in shares)	1,285	2,617	1,385	3,074
Weighted average shares outstanding - diluted (in shares)	162,529	169,707	164,427	171,027
Net income per share:
Basic (in dollars per share)	$ 0.87	$ 1.26	$ 1.98	$ 3.19
Diluted (in dollars per share)	$ 0.86	$ 1.24	$ 1.96	$ 3.14
Anti-dilutive equivalents shares excluded (in shares)	1,600	800	2,000	900

Employee Benefit Plans - Share-

Employee Benefit Plans - Share-based Compensation Expenses and Related Tax Benefits Recognized (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Share-based compensation expense and related tax benefit
Total share-based compensation expense	$ 15,805	$ 24,792	$ 51,740	$ 72,465
Income tax benefit	(3,276)	(3,581)	(7,496)	(23,460)
Total share-based compensation expense, net of income tax benefit	12,529	21,211	44,244	49,005
Cost of goods sold
Share-based compensation expense and related tax benefit
Total share-based compensation expense	1,324	1,782	4,228	5,253
Marketing and selling
Share-based compensation expense and related tax benefit
Total share-based compensation expense	8,014	10,699	25,240	28,987
Research and development
Share-based compensation expense and related tax benefit
Total share-based compensation expense	2,756	4,510	11,568	14,295
General and administrative
Share-based compensation expense and related tax benefit
Total share-based compensation expense	$ 3,711	$ 7,801	$ 10,704	$ 23,930

Employee Benefit Plans - Narrat

Employee Benefit Plans - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Share-Based Payment Arrangement [Abstract]
Share-based compensation expenses capitalized as inventory	$ 1.3	$ 1.1	$ 4.4	$ 4.1
Net periodic benefit cost	$ 2.7	$ 3.4	$ 8.3	$ 10

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
Income Taxes (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Mar. 31, 2022
Income Tax Disclosure [Abstract]
Provision for income taxes	$ 42,663	$ 49,345	$ 87,751	$ 107,789
Effective income tax rates (as a percent)	23.30%	19%	21.40%	16.70%
Discrete tax provision (benefit) from recognition of excess tax benefits	$ (200)	$ (800)	$ (1,400)	$ (15,200)
Expense (benefit) related to reversal of uncertain tax positions	(1,700)	$ (1,300)	(3,200)	$ (2,800)
Unrecognized tax benefits	184,000		184,000		$ 176,000
Income taxes payable	117,608		117,608		83,380
Accrued interest and penalties related to uncertain tax positions	5,200		5,200		$ 3,600
Expected decrease in uncertain tax positions	$ 4,300		$ 4,300

Balance Sheet Components - Comp

Balance Sheet Components - Components of Certain Balance Sheet Asset Amounts (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Mar. 31, 2022
Accounts receivable, net:
Accounts receivable	$ 1,121,377	$ 964,766
Accounts receivable, net	802,435	675,604
Inventories:
Raw materials	202,798	226,155
Finished goods	594,897	706,969
Inventory, net	797,695	933,124
Other current assets:
Value-added tax ("VAT") receivables	51,681	58,850
Prepaid expenses and other assets	73,407	76,628
Other current assets, total	125,088	135,478
Property, plant and equipment, net:
Property, plant and equipment	496,830	459,413
Less: accumulated depreciation and amortization	(378,647)	(349,606)
Property, plant and equipment, net	118,183	109,807
Other assets:
Deferred tax assets	190,558	193,629
Investments in privately held companies	32,600	43,068
Right-of-use assets	69,953	40,661
Investments for deferred compensation plan	27,665	28,431
Other assets	15,103	14,933
Other assets, total	335,879	320,722
Allowance for doubtful accounts
Accounts receivable, net:
Valuation allowance for accounts receivable	0	(2,212)
Allowance for sales returns
Accounts receivable, net:
Valuation allowance for accounts receivable	(14,021)	(12,321)
Allowance for cooperative marketing arrangements
Accounts receivable, net:
Valuation allowance for accounts receivable	(62,734)	(56,372)
Allowance for customer incentive programs
Accounts receivable, net:
Valuation allowance for accounts receivable	(114,160)	(97,460)
Allowance for pricing programs
Accounts receivable, net:
Valuation allowance for accounts receivable	$ (128,027)	$ (120,797)

Balance Sheet Components - Co_2

Balance Sheet Components - Components of Certain Balance Sheet Liability Amounts (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Mar. 31, 2022
Accrued and other current liabilities:
Accrued customer marketing, pricing and incentive programs	$ 238,518	$ 232,393
Accrued personnel expenses	113,486	165,090
Accrued sales return liability	42,743	40,507
Warranty accrual	29,999	32,987
VAT payable	34,149	39,602
Income taxes payable	17,839	35,355
Accrued payables - non-inventory	18,398	26,722
Operating lease liabilities	11,577	13,690
Contingent consideration	6,368	8,042
Other current liabilities	192,492	190,460
Accrued and other current liabilities	705,569	784,848
Other non-current liabilities:
Employee benefit plan obligations	49,082	50,741
Operating lease liabilities	61,414	28,207
Obligation for deferred compensation plan	27,665	28,431
Warranty accrual	12,632	13,232
Deferred tax liabilities	3,500	1,962
Contingent consideration	245	4,217
Other non-current liabilities	11,377	5,343
Non-current liabilities	$ 165,915	$ 132,133

Balance Sheet Components - Narr

Balance Sheet Components - Narrative (Details) $ in Millions	9 Months Ended
	Dec. 31, 2022 USD ($)
Balance Sheet Related Disclosures [Abstract]
Increase in right-of-use assets	$ 43
Increase in operating lease liabilities	$ 43

Fair Value Measurements - Finan

Fair Value Measurements - Financial Assets and Liabilities, Classified by Level (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Mar. 31, 2022
Liabilities:
Contingent consideration included in accrued and other current liabilities	$ 6,368	$ 8,042
Contingent consideration included in other non-current liabilities	245	4,217
Fair Value, Measurements, Recurring \| Level 1
Assets:
Cash equivalents	603,163	762,055
Investments for deferred compensation plan	27,665	28,431
Currency derivative assets included in other current assets	0	0
Liabilities:
Contingent consideration included in accrued and other current liabilities	0	0
Contingent consideration included in other non-current liabilities	0	0
Currency derivative liabilities included in accrued and other current liabilities	0	0
Fair Value, Measurements, Recurring \| Level 1 \| Cash
Assets:
Investments for deferred compensation plan	10	108
Fair Value, Measurements, Recurring \| Level 1 \| Common stock
Assets:
Investments for deferred compensation plan	705	2,329
Fair Value, Measurements, Recurring \| Level 1 \| Money market funds
Assets:
Investments for deferred compensation plan	9,728	6,765
Fair Value, Measurements, Recurring \| Level 1 \| Mutual funds
Assets:
Investments for deferred compensation plan	17,222	19,229
Fair Value, Measurements, Recurring \| Level 2
Assets:
Cash equivalents	0	0
Investments for deferred compensation plan	0	0
Currency derivative assets included in other current assets	668	1,517
Liabilities:
Contingent consideration included in accrued and other current liabilities	0	0
Contingent consideration included in other non-current liabilities	0	0
Currency derivative liabilities included in accrued and other current liabilities	3,519	165
Fair Value, Measurements, Recurring \| Level 2 \| Cash
Assets:
Investments for deferred compensation plan	0	0
Fair Value, Measurements, Recurring \| Level 2 \| Common stock
Assets:
Investments for deferred compensation plan	0	0
Fair Value, Measurements, Recurring \| Level 2 \| Money market funds
Assets:
Investments for deferred compensation plan	0	0
Fair Value, Measurements, Recurring \| Level 2 \| Mutual funds
Assets:
Investments for deferred compensation plan	0	0
Fair Value, Measurements, Recurring \| Level 3
Assets:
Cash equivalents	0	0
Investments for deferred compensation plan	0	0
Currency derivative assets included in other current assets	0	0
Liabilities:
Contingent consideration included in accrued and other current liabilities	6,368	8,042
Contingent consideration included in other non-current liabilities	0	3,971
Currency derivative liabilities included in accrued and other current liabilities	0	0
Fair Value, Measurements, Recurring \| Level 3 \| Cash
Assets:
Investments for deferred compensation plan	0	0
Fair Value, Measurements, Recurring \| Level 3 \| Common stock
Assets:
Investments for deferred compensation plan	0	0
Fair Value, Measurements, Recurring \| Level 3 \| Money market funds
Assets:
Investments for deferred compensation plan	0	0
Fair Value, Measurements, Recurring \| Level 3 \| Mutual funds
Assets:
Investments for deferred compensation plan	$ 0	$ 0

Fair Value Measurements - Chang

Fair Value Measurements - Change in Fair Value of Contingent Consideration (Details) - USD ($) $ in Thousands	9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Change in Fair Value of Contingent Consideration [Roll Forward]
Beginning of the period	$ 12,259	$ 6,967
Fair value of contingent consideration upon acquisition	2,151	9,973
Change in fair value of contingent consideration	0	(3,509)
Settlement of contingent consideration	(5,954)	(880)
Effect of foreign currency exchange rate changes	(1,843)	0
End of the period	$ 6,613	$ 12,551

Fair Value Measurements - Narra

Fair Value Measurements - Narrative (Details)		3 Months Ended			9 Months Ended
Fair Value Measurements - Narrative (Details)	May 19, 2021 USD ($) milestone	Dec. 31, 2022 USD ($)	Sep. 30, 2022 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Mar. 31, 2022 USD ($)	Mar. 31, 2021 USD ($)	Feb. 17, 2021 USD ($)	Jan. 04, 2021 USD ($) milestone
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of contingent consideration upon acquisition					$ 2,151,000	$ 9,973,000
Payment of contingent consideration for business acquisition					5,954,000	880,000
Equity method investments		$ 21,300,000			21,300,000		$ 40,200,000
Impairment of non-marketable investments		0		$ 0	21,400,000	0
Equity investments included in other assets		10,900,000			10,900,000		2,900,000
Unrealized gain, before tax					6,900,000
Impairment of long-lived assets held-for-use		0		0	0	0
Impairment of non-financial assets		0			0
Impairment of intangible assets		0		7,000,000	0	$ 7,000,000
Fair Value, Measurements, Recurring \| Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments for deferred compensation plan		27,665,000			27,665,000		$ 28,431,000
Small Technology Acquisition
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Future potential earn-out payments	$ 10,000,000
Number of technical development milestones \| milestone	3
Fair value of contingent consideration upon acquisition	$ 10,000,000
Small Technology Acquisition \| First Technical Development Milestone
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Payment of contingent consideration for business acquisition				$ 900,000
Small Technology Acquisition \| Second Technical Development Milestone
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Payment of contingent consideration for business acquisition			$ 4,000,000
Mevo
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Future potential earn-out payments									$ 17,000,000
Contingent consideration								$ 3,400,000
Second Small Technology Acquisition
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Future potential earn-out payments										$ 3,000,000
Number of technical development milestones \| milestone										2
Second Small Technology Acquisition \| First Technical Development Milestone
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Payment of contingent consideration for business acquisition			$ 2,000,000
Second Small Technology Acquisition \| Second Technical Development Milestone
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent consideration		$ 1,000,000			$ 1,000,000

Derivative Financial Instrume_3

Derivative Financial Instruments - Narrative (Details) - USD ($) $ in Thousands	9 Months Ended
	Dec. 31, 2022	Sep. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Mar. 31, 2021
Derivative [Line Items]
Equity	$ 2,258,666	$ 2,168,561	$ 2,398,738	$ 2,367,942	$ 2,262,683	$ 2,261,789
Deferred Hedging Gains (Losses)
Derivative [Line Items]
Equity	$ (4,694)		1,833
Not Designated as Hedging Instrument \| Foreign Exchange Forward And Swap
Derivative [Line Items]
Derivative term of contract	1 month
Foreign Exchange Forward \| Designated as hedging instruments \| Cash flow hedges
Derivative [Line Items]
Derivative term of contract	4 months
Derivative, notional amount	$ 111,700		125,400
Foreign Exchange Forward \| Designated as hedging instruments \| Cash flow hedges \| Deferred Hedging Gains (Losses)
Derivative [Line Items]
Equity	(4,700)
Foreign Exchange Forward And Swap \| Not Designated as Hedging Instrument
Derivative [Line Items]
Derivative, notional amount	$ 217,600		$ 226,500

Derivative Financial Instrume_4

Derivative Financial Instruments - Gains and Losses on Derivative Instruments (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Amounts of gains and losses on the derivative instruments
Amount of Gain Deferred as a Component of Accumulated Other Comprehensive Loss	$ (6,325)	$ 1,061	$ 5,239	$ 3,723
Amount of Gain Reclassified from Accumulated Other Comprehensive Loss to Costs of Goods Sold	(4,728)	(3,200)	(11,766)	(5,108)
Designated as hedging instruments \| Cash flow hedges
Amounts of gains and losses on the derivative instruments
Amount of Gain Deferred as a Component of Accumulated Other Comprehensive Loss	(6,325)	1,061	5,239	3,723
Amount of Gain Reclassified from Accumulated Other Comprehensive Loss to Costs of Goods Sold	$ (4,728)	$ (3,200)	$ (11,766)	$ (5,108)

Goodwill and Other Intangible_3

Goodwill and Other Intangible Assets - Summary of Activity In Goodwill Balance (Details) $ in Thousands	9 Months Ended
	Dec. 31, 2022 USD ($)
Goodwill
Balance at the beginning of the period	$ 448,175
Acquisitions	7,976
Effects of foreign currency translation	(1,680)
Balance at the end of the period	$ 454,471

Goodwill and Other Intangible_4

Goodwill and Other Intangible Assets - Schedule of Intangible Assets Subject to Amortization (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Mar. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 233,879	$ 230,499
Accumulated Amortization	(164,515)	(146,720)
Net Carrying Amount	69,364	83,779
Effects of foreign currency translation, Gross Carrying Amount	(1,077)	(634)
Effects of foreign currency translation, Accumulated Amortization	356	86
Effects of foreign currency translation, Net Carrying Amount	(721)	(548)
In-process R&D
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	3,526	3,826
Net Carrying Amount	3,526	3,826
Trademark and trade names
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	36,790	36,790
Accumulated Amortization	(25,787)	(22,295)
Net Carrying Amount	11,003	14,495
Developed technology
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	123,530	119,407
Accumulated Amortization	(93,058)	(83,540)
Net Carrying Amount	30,472	35,867
Customer contracts/relationships
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	71,110	71,110
Accumulated Amortization	(46,026)	(40,971)
Net Carrying Amount	$ 25,084	$ 30,139

Goodwill and Other Intangible_5

Goodwill and Other Intangible Assets - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]
Impairment of intangible assets	$ 0	$ 7,000	$ 0	$ 7,000

Financing Arrangements (Details

Financing Arrangements (Details) - Line of Credit - USD ($)	Dec. 31, 2022	Mar. 31, 2022
Financing Arrangements
Maximum borrowing capacity	$ 179,200,000	$ 195,000,000
Outstanding bank guarantees	11,600,000	25,500,000
Outstanding borrowings	$ 0	$ 0

Commitments and Contingencies -

Commitments and Contingencies - Changes in Warranty Liability (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Changes in the warranty liability:
Beginning of the period	$ 41,960	$ 49,173	$ 46,219	$ 48,832
Provision	8,920	6,962	23,440	23,503
Settlements	(8,979)	(8,056)	(26,358)	(24,219)
Effects of foreign currency translation	730	(144)	(670)	(181)
End of the period	$ 42,631	$ 47,935	$ 42,631	$ 47,935

Commitments and Contingencies_2

Commitments and Contingencies - Narrative (Details)	Dec. 31, 2022 USD ($)
Indemnification agreement
Other Commitments [Line Items]
Amount accrued for indemnification provisions	$ 0

Shareholders' Equity - Narrativ

Shareholders' Equity - Narrative (Details) $ / shares in Units, shares in Millions	1 Months Ended		9 Months Ended
	Jul. 31, 2022 USD ($) shares	Apr. 30, 2021 USD ($)	Dec. 31, 2022 USD ($) $ / shares	Dec. 31, 2022 USD ($) SFr / shares	Dec. 31, 2021 USD ($) $ / shares	Dec. 31, 2021 SFr / shares	May 31, 2020 USD ($) shares
Class of Stock [Line Items]
Cash dividends per share (in dollars per share) \| (per share)			$ 1	SFr 0.96	$ 0.95	SFr 0.87
Payment of cash dividends			$ 162,681,000		$ 159,410,000
May 2020
Class of Stock [Line Items]
Authorized amount in buyback program	$ 1,500,000,000	$ 1,000,000,000					$ 250,000,000
Shares authorized to be repurchased (in shares) \| shares	17.3						17.3
Increase in authorized amount	$ 500,000,000	$ 750,000,000
Amount available for repurchase			$ 596,300,000	SFr 596,300,000
Period to complete share repurchase program	3 years

Shareholders' Equity - Componen

Shareholders' Equity - Components of Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Accumulated Other Comprehensive Income (Loss)
Beginning of the period	$ 2,168,561	$ 2,262,683	$ 2,398,738	$ 2,261,789
Other comprehensive income (loss)	22,026	(8,177)	(12,845)	(10,281)
End of the period	2,258,666	2,367,942	2,258,666	2,367,942
Cumulative Translation Adjustment
Accumulated Other Comprehensive Income (Loss)
Beginning of the period			(102,461)
Other comprehensive income (loss)			(5,988)
End of the period	(108,449)		(108,449)
Defined Benefit Plans
Accumulated Other Comprehensive Income (Loss)
Beginning of the period			(3,495)
Other comprehensive income (loss)			(330)
End of the period	(3,825)		(3,825)
Deferred Hedging Gains (Losses)
Accumulated Other Comprehensive Income (Loss)
Beginning of the period			1,833
Other comprehensive income (loss)			(6,527)
End of the period	(4,694)		(4,694)
Total
Accumulated Other Comprehensive Income (Loss)
Beginning of the period	(138,994)	(111,019)	(104,123)	(108,915)
End of the period	$ (116,968)	$ (119,196)	$ (116,968)	$ (119,196)

Segment Information - Net Sales

Segment Information - Net Sales by Product Categories, Excluding Intercompany Transactions (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Segment Reporting Information [Line Items]
Net sales	$ 1,269,925	$ 1,632,782	$ 3,578,741	$ 4,251,107
Pointing Devices
Segment Reporting Information [Line Items]
Net sales	199,106	231,090	567,589	602,982
Keyboards & Combos
Segment Reporting Information [Line Items]
Net sales	220,059	281,608	648,632	736,237
PC Webcams
Segment Reporting Information [Line Items]
Net sales	58,481	115,115	178,033	319,504
Tablet & Other Accessories
Segment Reporting Information [Line Items]
Net sales	65,157	82,859	185,945	242,932
Gaming
Segment Reporting Information [Line Items]
Net sales	391,975	469,282	972,457	1,135,456
Video Collaboration
Segment Reporting Information [Line Items]
Net sales	226,374	287,187	708,796	753,725
Mobile Speakers
Segment Reporting Information [Line Items]
Net sales	38,321	56,748	99,826	124,724
Audio & Wearables
Segment Reporting Information [Line Items]
Net sales	69,104	104,280	211,821	318,965
Other
Segment Reporting Information [Line Items]
Net sales	$ 1,348	$ 4,613	$ 5,642	$ 16,582

Segment Information - Net Sal_2

Segment Information - Net Sales and Long-Lived Assets by Geographic Region (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Mar. 31, 2022
Net sales to unaffiliated customers and long-lived assets by geographic region
Net sales	$ 1,269,925	$ 1,632,782	$ 3,578,741	$ 4,251,107
Property, plant and equipment, net	166,285		166,285		$ 133,673
Americas
Net sales to unaffiliated customers and long-lived assets by geographic region
Net sales	513,835	674,393	1,508,318	1,828,474
Property, plant and equipment, net	49,447		49,447		22,578
EMEA
Net sales to unaffiliated customers and long-lived assets by geographic region
Net sales	428,532	552,133	1,016,187	1,309,542
Property, plant and equipment, net	38,380		38,380		23,830
Asia Pacific
Net sales to unaffiliated customers and long-lived assets by geographic region
Net sales	327,558	$ 406,256	1,054,236	$ 1,113,091
Property, plant and equipment, net	$ 78,458		$ 78,458		$ 87,265

Segment Information - Narrative

Segment Information - Narrative (Details) $ in Thousands	3 Months Ended		9 Months Ended
Segment Information - Narrative (Details) $ in Thousands	Dec. 31, 2022 USD ($)	Dec. 31, 2021	Dec. 31, 2022 USD ($) segment	Dec. 31, 2021	Mar. 31, 2022 USD ($)
Segment Reporting Information [Line Items]
Number of operating segments (in segments) \| segment			1
Long lived assets	$ 166,285		$ 166,285		$ 133,673
Switzerland
Segment Reporting Information [Line Items]
Long lived assets	12,900		12,900		13,600
United States
Segment Reporting Information [Line Items]
Long lived assets	48,900		48,900		21,700
China
Segment Reporting Information [Line Items]
Long lived assets	56,800		56,800		66,800
IRELAND
Segment Reporting Information [Line Items]
Long lived assets	$ 17,600		$ 17,600		$ 900
Geographic Concentration \| Consolidated net sales from continuing operations \| Switzerland
Segment Reporting Information [Line Items]
Percentage of consolidated net sales	4%	3%	3%	3%

Restructuring (Details)

Restructuring (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
Restructuring (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Restructuring Cost and Reserve [Line Items]
Restructuring charges, net	$ 5,654	$ 1,759	$ 16,471	$ 1,770
Impairment of intangible assets	0	7,000	0	7,000
Discontinued operations
Restructuring Cost and Reserve [Line Items]
Inventory write-offs in cost of goods sold		7,600		7,600
Employee severance termination benefits
Restructuring Cost and Reserve [Line Items]
Restructuring charges, net			11,300
Restructuring reserve	3,600		3,600
Contract termination
Restructuring Cost and Reserve [Line Items]
Restructuring charges, net	5,700		5,200
Restructuring reserve	4,700		4,700
Employee severance and contract termination costs
Restructuring Cost and Reserve [Line Items]
Restructuring reserve	$ 8,300		$ 8,300
Purchase order cancellation fees \| Discontinued operations
Restructuring Cost and Reserve [Line Items]
Restructuring charges, net		$ 1,800		$ 1,800